Home › Funds › Commodore Capital LP › ASMB
Commodore Capital LP position in ASMB
ASSEMBLY BIOSCIENCES INC · Health Care
Commodore Capital LP reported holding 1,415,000 shares of ASMB (ASSEMBLY BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$38.9M, representing 2.32% of its reported portfolio and ranking #16 among its reported holdings. Commodore Capital LP has disclosed ASMB holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Commodore Capital LP's ASMB position evolved
Commodore Capital LP first disclosed a stake in ASMB in Q3 2025 at 1,000,000 shares (US$25.6M). The position peaked in Q2 2026 at 1,415,000 shares, worth US$38.9M. Across 4 filings, Commodore Capital LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 1,415,000 shares valued at US$38.9M — an increase of 415,000 shares quarter over quarter.. Notable position changes include a 42% increase in Q2 2026 (shares fell 15% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 1.00M | $25.60M | New |
| Q4 2025 | 1.00M | $34.01M | Hold |
| Q1 2026 | 1.00M | $27.75M | Hold |
| Q2 2026 | 1.42M | $38.88M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ASMB and 13F data
ASMB (ASSEMBLY BIOSCIENCES INC) is a Health Care company. 60 other funds we track also report a position in ASMB — the largest reported positions include GILEAD SCIENCES, INC. (US$136.8M), Farallon Capital Management (US$44.1M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$44.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ASMB
- GILEAD SCIENCES, INC. 4.98M sh · $136.77M · Q2 2026
- Farallon Capital Management 1.60M sh · $44.09M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 1.60M sh · $44.09M · Q2 2026
- Paradigm Biocapital Advisors LP 1.55M sh · $42.70M · Q2 2026
- Parkman Healthcare Partners LLC 721.18K sh · $19.82M · Q2 2026
- Seven Fleet Capital Management LP 433.15K sh · $11.90M · Q2 2026
- DV EQUITIES, LLC 226.41K sh · $6.22M · Q2 2026
- B Group, Inc. 175.71K sh · $4.83M · Q2 2026
- STEMPOINT CAPITAL LP 170.38K sh · $4.68M · Q2 2026
- Squadron Capital Management LLC 160.00K sh · $4.40M · Q2 2026
- Ally Bridge Group (NY) LLC 140.00K sh · $3.85M · Q2 2026
More on Commodore Capital LP
FAQ
How long has Commodore Capital LP held ASMB?
Commodore Capital LP has disclosed ASMB holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is Commodore Capital LP's current position in ASMB?
As of Q2 2026, Commodore Capital LP holds 1.42M shares of ASMB (ASSEMBLY BIOSCIENCES INC), valued at $38.88M, representing 2.32% of its reported portfolio and ranking #16.
Has Commodore Capital LP been buying or selling ASMB?
In the latest 13F filing (Q2 2026), Commodore Capital LP increased its position in ASMB. The position peaked in Q2 2026 at 1.42M shares.
Which other funds hold ASMB?
Other major institutional holders of ASMB include GILEAD SCIENCES, INC., Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 60 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.